Bùi Văn Thuỵ (2014). Nghiên Cứu Mật Độ Xương Và Chỉ Số Khối Cơ Thể Ở

40. Newman AB, Kupelian V, Visser M et al (2003). Sarcopenia: alternative definitions and associations with lower extremity function. 51(11), 16021609.

41. Janssen I, Heymsfield SB, Ross RJJotAGS (2002). Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. 50(5), 889896.

42. Cawthon PM, Peters KW, Shardell MD et al (2014). Cutpoints for low appendicular lean mass that identify older adults with clinically significant weakness. 69(5), 567575.

43. Vermeulen J, Neyens J.C.L, van Rossum E et al (2011). Predicting ADL disability in communitydwelling elderly people using physical frailty indicators: a systematic review. BMC geriatrics, 11(1), 33.

44. Podsiadlo D and Richardson S (1991). The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. Journal of the American geriatrics Society, 39(2), 142148.

45. Roberts H.C, Denison H.J, Martin H.J et al (2011). A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age and ageing, afr051.

46. Landi F, Liperoti R, Russo A et al (2012). Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr, 31(5), 652658.

47. Cawthon P.M, Blackwell T.L, Cauley J et al (2015). Evaluation of the Usefulness of Consensus Definitions of Sarcopenia in Older Men: Results from the Observational Osteoporotic Fractures in Men Cohort Study. J Am Geriatr Soc, 63(11), 22472259.

48. Tanimoto Y, Watanabe M, Sun W et al (2013). Association of sarcopenia with functional decline in communitydwelling elderly subjects in Japan. Geriatr Gerontol Int, 13(4), 958963.

49. Janssen I, Shepard D.S, Katzmarzyk P.T et al (2004). The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc, 52(1), 80 85.

Có thể bạn quan tâm!

Xem toàn bộ 262 trang tài liệu này.

50. SánchezRodríguez D, Marco E, Miralles R et al (2015). Does gait speed contribute to sarcopenia casefinding in a postacute rehabilitation setting? Arch Gerontol Geriatr, 61(2), 176181.

51. Kim K.M, Lim S, Choi K.M et al (2015). Sarcopenia Study Group of Korean Geriatrics Society. Sarcopenia in Korea: prevalence and clinical aspects. J Korean Geriatr Soc 19(1), 18.

52. John E. M (2018). Treatment of sarcopenia: the road to the future. J Cachexia Sarcopenia Muscle, 9(7), 1196–1199.

53. Yoo S.Z, No M.H, Heo J.W et al (2018). Role of exercise in agerelated sarcopenia. Journal of exercise rehabilitation, 14(4), 551–558.

54. Park S.W, Goodpaster B.H, Lee J.S et al (2009). Health, Aging, and Body Composi tion Study. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care, 32(11), 19931997.

55. Sayer A.A, Dennison E.M, Syddall H.E et al (2005). Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg? Diabetes care, 28(10), 25412542.

56. Ucok K, Yalcinkaya H, Acay A et al (2015). Do patients with newly diagnosed type 2 diabetes have impaired physical fitness, and energy expenditures? Neth J Med, 73(6), 276283.

57. Trierweiler H, Kisielewicz G, Hoffmann Jonasson T et al (2018). Sarcopenia: a chronic complication of type 2 diabetes mellitus. Diabetol Metab Syndr, 10, 25.

58. Bùi Văn Thuỵ (2014). Nghiên cứu mật độ xương và chỉ số khối cơ thể ở bệnh nhân nữ đái tháo đường typ2 đã mạn kinh, Luận văn tốt nghiệp thạc sĩ, Trường Đại học Y Hà Nội.

59. Nguyễn Thu Hương (2018). Sacropenia và mối liên quan ở bệnh nhân đái tháo đường typ 2 cao tuổi.

60. Mesinovic J, Zengin A, De Courten B et al (2019). Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes Metab Syndr Obes, 12, 10571072.

61. Turner N and Heilbronn L.K (2008). Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol Metab, 19(9), 324330.

62. Chung T.H, Kwon Y.J, Shim J.Y et al (2016). Association between serum triglyceride to highdensity lipoprotein cholesterol ratio and sarcopenia in elderly Korean males: The Korean National Health and Nutrition Examination Survey. Clin Chim Acta, 463, 165168.

63. Shinohara M and Sato N (2017). Bidirectional interactions between diabetes and Alzheimer's disease. Neurochem Int, 108, 296302.

64. McKenzie D, Bua E, McKiernan S et al (2002). Mitochondrial DNA deletion mutations: a causal role in sarcopenia. Eur J Biochem, 269(8), 20102015.

65. Candow D.G and Chilibeck P.D (2007). Effect of creatine supplementation during resistance training on muscle accretion in the elderly. J Nutr Health Aging, 11(2), 185188.

66. Roubenoff R, Parise H, Payette H.A et al (2003). Cytokines, insulin like growth factor 1, sarcopenia, and mortality in very old community

dwelling men and women: the Framingham Heart Study. Am J Med,

115(6), 429435.

67. Phillips T and Leeuwenburgh C (2005). Muscle fiber specific apoptosis and TNFα signaling in sarcopenia are attenuated by lifelong calorie restriction. FASEB J, 19(6), 668670.

68. Goodpaster B.H, Thaete F.L, Kelley D.E (2000). Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr, 71(4), 885892.

69. Maty S.C, Fried L.P, Volpato S et al (2004). Patterns of disability related to diabetes mellitus in older women. J Gerontol A Biol Sci Med Sci, 59(2), 148153.

70. Yang Q, Zhang Y, Zeng Q et al (2020). Correlation Between Diabetic Peripheral Neuropathy and Sarcopenia in Patients with Type 2 Diabetes Mellitus and Diabetic Foot Disease: A CrossSectional Study. Diabetes Metab Syndr Obes, 13, 377386.

71. Guccione A.A, Felson D.T, Anderson J.J et al (1994). The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health, 84(3), 351358.

72. Momma H, Niu K, Kobayashi Y et al (2011). Skin advanced glycation end product accumulation and muscle strength among adult men. 111(7), 15451552.

73. Volpato S, Ferrucci L, Blaum C et al (2002). Progression of Lower Extremity Disability in Older Women With Diabetes The Women’s Health and Aging Study. Diabetes care 26, 7075.

74. Andreassen CS, Jakobsen J, Andersen H (2006). Muscle weakness: a progressive late complication in diabetic distal symmetric polyneuropathy. Diabetes, 55(3), 806812.

75. Houston D.K, Cesari M, Ferrucci L et al (2007). Association between vitamin D status and physical performance: the InCHIANTI study. J Gerontol A Biol Sci Med Sci, 62(4), 440446.

76. Gauhan D.J, Barbaux S, Kluijtman L.A et al (2000). The human and mouse methylenetetrahydrofolat reductase genes: genomic organization, mRNA structure and likage to the CLCN6 gene. Gene, 257(2), 279 289.

77. Kanwar Y.S, Manaligod J.R, Wong P.W (1976). Morphologic Studies in a Patient with Homocystinuria due to 5,10 Methylenetetrahydrofolate Reductase Deficiency. Pediatrics, 10(6), 598 609.

78. Rodgers G.M and Conn M.T (1990). Homocystein, an athrogenic stimulus reduces protein C activation by arterial and venous endothelial cells. Blood, 75(4), 895 901.

79. Rodgers G.M, Kane W.H (1986). Activation of endogenous factor V by a homocystein induced vascular endothelial cell activator. J Clin Invest, 77(6), 1909 1916.

80. Di Renzo L, Marsella L.T, Sarlo F et al (2014). C677T gene polymorphism of MTHFR and metabolic syndrome: response to dietary intervention. J Transl Med, 12, 329.

81. Landi F, Liperoti R, Fusco D et al (2011). Prevalence and risk factors of sarcopenia among nursing home older residents. The Journals of Gerontology Series A, Biomedical Sciences and Medical Sciences, 67(1), 4855.

82. Patel H.P, Syddall H.E, Jameson K et al (2013). Prevalence of sarcopenia in communitydwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP)

definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing, 42(3), 378384.

83. Murata Y, Kadoya Y, Yamada S et al (2018). Sarcopenia in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factors. Diabetol Int, 9(2), 136142.

84. Wannamethee SG, Atkins JLJPotNS (2015). Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity. 74(4), 405412.

85. Yu R, Wong M, Leung J et al (2014). Incidence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community‐dwelling older C hinese adults. 14, 1528.

86. Sugimoto K, Tabara Y, Ikegami H et al (2019). Hyperglycemia in non obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus. J Diabetes Investig, 10(6), 14711479.

87. Baek S.J, Nam G.E, Han K.D et al (2014). Sarcopenia and sarcopenic obesity and their associa tion with dyslipidemia in Korean elderly men: the 2008–2010 Korea National Health and Nutrition Examination Survey. J Endocrinol Investig, 37, 247–260.

88. Bai T, Fang F, Li F et al (2020). Sarcopenia is associated with hypertension in older adults: a systematic review and metaanalysis. BMC Geriatrics, 20(1), 279.

89. Coelho Júnior H.J, Aguiar S, Gonçalves I et al (2015). Sarcopenia is associated with high pulse pressure in older women. Journal of aging research, 2015.

90. Yoon JW, Ha YC, Kim KM et al (2016). Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean longitudinal study on health and aging. 40(2), 140146.

91. Kalyani RR, Metter EJ, Egan J et al (2015). Hyperglycemia predicts persistently lower muscle strength with aging. 38(1), 8290.

92. Di Stasi S.L, MacLeod T.D, Winters J.D et al (2010). Effects of statins on skeletal muscle: a perspective for physical therapists. Phys Ther, 90(10), 15301542.

93. Onder G, Penninx B.W, Balkrishnan R et al (2002). Relation between use of angiotensinconverting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet, 359(9310), 926930.

94. Miles D.W, Deepa S, Marion E. T. M (2008). ACE inhibitors for sarcopenia—as good as exercise training? . 37(4), 363365.

95. Burks T.N, AndresMateos E, Marx R et al (2011). Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Sci Transl Med, 3(82), 82ra37.

96. Musi N, Hirshman M.F, Nygren J et al (2002). Metformin increases AMPactivated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes, 51(7), 20742081.

97. Miyazaki Y, Mahankali A, Matsuda M et al (2002). Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab, 87(6), 27842791.

98. Abdulla H, Phillips B, Smith K et al (2014). Physiological mechanisms of action of incretin and insulin in regulating skeletal muscle metabolism. Curr Diabetes Rev, 10(5), 327335.

99. Beveridge LA, Ramage L, McMurdo ME et al (2013). Allopurinol use is associated with greater functional gains in older rehabilitation patients. 42(3), 400404.

100. Ametller E, Busquets S, Fuster G et al (2011). Formoterol may activate rat muscle regeneration during cancer cachexia. 1(1), 117.

101. Toledo M, Springer J, Busquets S et al (2014). Formoterol in the treatment of experimental cancer cachexia: effects on heart function. 5(4), 315320.

102. Flicker L, Mead K, MacInnis RJ et al (2003). Serum vitamin D and falls in older women in residential care in Australia. 51(11), 15331538.

103. Ceglia L, Niramitmahapanya S, da Silva Morais M et al (2013). A randomized study on the effect of vitamin D3 supplementation on skeletal muscle morphology and vitamin D receptor concentration in older women. 98(12), E1927E1935.

104. Morley J.E, Vellas B, van Kan G.A et al (2013). Frailty consensus: a call to action. J Am Med Dir Assoc, 14(6), 392397.

105. Cacciatore F, Testa G, Galizia G et al (2013). Clinical frailty and long term mortality in elderly subjects with diabetes. Acta Diabetol 50(2), 251–260.

106. Kim K.S, Park K.S, Kim M.J et al (2014). Type 2 diabetes is associated with low muscle mass in older adults. Geriatr Gerontol Int, 14(1), 115 121.

107. Willey K.A and Singh M.A (2003). Battling insulin resistance in elderly obese people with type 2 diabetes: bring on the heavy weights. Diabetes Care, 26(5), 15801588.

108. Dunstan D.W, Daly R.M, Owen N et al (2005). Homebased resistance training is not sufficient to maintain improved glycemic control